yahoo_financeOriginal article
Polaryx Therapeutics Announces Closing of $10 Million Private Placement Equity Financing to Support Launch of SOTERIA Phase 2 Basket Trial
SOTERIAPositive
AI Analysis
Summary
Polaryx Therapeutics closed a $10 million private placement equity financing to support the launch of the SOTERIA Phase 2 basket trial.
Clinical Trial Data
Phase
Phase 2
Importance:5/10
Sentiment:
0.50
private placementequity financingPhase 2 trialbasket trial
Related Companies
Read the original article
Published by yahoo_finance on May 28, 2026 12:30 PM